Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |